Alexander A Fitzpatrick insider trades

Open-market stock purchases and sales by Alexander A Fitzpatrick, Chief Legal Officer at ARS Pharmaceuticals, Inc, from SEC Form 4 filings since Nov 9, 2010.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +53%.

Recent trades

DateStockTradeValue
Jun 12, 2026SPRY ARS Pharmaceuticals, IncSold$33.5K
Jan 2, 2026SPRY ARS Pharmaceuticals, IncBought (not open market)—

Companies traded

  • SPRY ARS Pharmaceuticals, Inc: 2 buys, 2 sales, last Jun 12, 2026
  • EVFM Evofem Biosciences, Inc: 5 buys, last Feb 18, 2022
  • VRNM Verenium Corp: 2 buys, last Oct 31, 2013

Get free alerts when Alexander A Fitzpatrick files a new trade →